(Q37887186)

24 August 2017

1 reference

title

New clinical diagnostic procedures for cystic fibrosis in Europe (English)

1 reference

24 August 2017

0 references

0 references

0 references

K De Boeck

1

1 reference

24 August 2017

N Derichs

2

1 reference

24 August 2017

I Fajac

3

1 reference

24 August 2017

H R de Jonge

4

1 reference

24 August 2017

I Bronsveld

5

1 reference

24 August 2017

I Sermet

6

1 reference

24 August 2017

F Vermeulen

7

1 reference

24 August 2017

D N Sheppard

8

1 reference

24 August 2017

H Cuppens

9

1 reference

24 August 2017

M Hug

10

1 reference

24 August 2017

P Melotti

11

1 reference

24 August 2017

P G Middleton

12

1 reference

24 August 2017

M Wilschanski

13

1 reference

24 August 2017

ECFS Diagnostic Network Working Group

14

1 reference

24 August 2017

EuroCareCF WP3 Group on CF diagnosis

15

1 reference

24 August 2017

1 June 2011

1 reference

Journal of Cystic Fibrosis

24 August 2017

1 reference

24 August 2017

10 Suppl 2

1 reference

24 August 2017

S53-66

1 reference

Cystic fibrosis: terminology and diagnostic algorithms

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Nasal potential difference measurements in patients with atypical cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Bioelectric properties of the isolated amphibian lung.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Measurement of nasal potential difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Nasal potential difference in cystic fibrosis patients presenting borderline sweat test

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Nasal potential measurements on the nasal floor and under the inferior turbinate: does it matter?

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Impact of different chloride and glucose solutions on nasal potential difference.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Reproducibility of nasal potential difference measurements in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Airway ion transport impacts on disease presentation and severity in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Measurement of airway ion transport assists the diagnosis of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Airway surface liquid calcium modulates chloride permeability in the cystic fibrosis airway.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Hypertonic saline alters ion transport across the human airway epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

A multicenter study of the effect of solution temperature on nasal potential difference measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

A modified technique for measurement of nasal transepithelial potential difference in infants

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Nasal epithelial ion transport and genetic analysis of infertile men with congenital bilateral absence of the vas deferens

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Nasal potential difference in congenital bilateral absence of the vas deferens

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Recommendations for the classification of diseases as CFTR-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Hypertonic saline inhibits luminal sodium channels in respiratory epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Nasal epithelium potential difference at high altitude (4,559 m): evidence for secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Pulmonary disease severity in men with deltaF508 cystic fibrosis and residual chloride secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Nasal airway ion transport and lung function in young people with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

CFTR function and prospects for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Electrolyte transport in the mammalian colon: mechanisms and implications for disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Role of CFTR in the colon

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Chloride secretion by the intestinal epithelium: molecular basis and regulatory aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Intestinal ion transport and the pathophysiology of diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Residual chloride secretion in intestinal tissue of deltaF508 homozygous twins and siblings with cystic fibrosis. The European CF Twin and Sibling Study Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Failure of cholinergic stimulation to induce a secretory response from the rectal mucosa in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Assessment of CFTR function in native epithelia for the diagnosis of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Assessment of CFTR function in rectal biopsies for the diagnosis of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Determinants of mild clinical symptoms in cystic fibrosis patients. Residual chloride secretion measured in rectal biopsies in relation to the genotype

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

CFTR Cl− channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Mediated Residual Chloride Secretion Does Not Protect against Early Chronic Pseudomonas aeruginosa Infection in F508del Homozygous Cystic Fibrosis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Transepithelial electrical measurements with the Ussing chamber

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Defective cholinergic Cl(-) secretion and detection of K(+) secretion in rectal biopsies from cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Adrenaline-induced colonic K+ secretion is mediated by KCa1.1 (BK) channels.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Epac1 mediates protein kinase A-independent mechanism of forskolin-activated intestinal chloride secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Diversity of the basic defect of homozygous CFTR mutation genotypes in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Homozygosity for L997F in a child with normal clinical and chloride secretory phenotype provides evidence that this cystic fibrosis transmembrane conductance regulator mutation does not cause cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Could a defective epithelial sodium channel lead to bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Plasmodium falciparum-activated chloride channels are defective in erythrocytes from cystic fibrosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

Physiological concept for a blood based CFTR test.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2811%2960009-X

7 January 2021

10.1016/S1569-1993(11)60009-X

Identifiers

DOI

1 reference

24 August 2017

1 reference